Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group).

Bingham CO 3rd, Pohl C, Woodworth TG, Hewlett SE, May JE, Rahman MU, Witter JP, Furst DE, Strand CV, Boers M, Alten RE.

J Rheumatol. 2009 Oct;36(10):2335-41. doi: 10.3899/jrheum.090369. Epub 2009 Aug 14.

PMID:
19684147
2.

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.

Bykerk VP, Lie E, Bartlett SJ, Alten R, Boonen A, Christensen R, Furst DE, Hewlett S, Leong AL, Lyddiatt A, March L, May JE, Montie P, Orbai AM, Pohl C, Scholte Voshaar M, Woodworth T, Bingham CO 3rd, Choy EH.

J Rheumatol. 2014 Apr;41(4):799-809. doi: 10.3899/jrheum.131252. Epub 2014 Mar 1. Review.

3.

Minimal disease activity for rheumatoid arthritis: a preliminary definition.

Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, Aletaha D, Anderson JJ, Bombardier C, Dougados M, Emery P, Felson DT, Fransen J, Furst DE, Hazes JM, Johnson KR, Kirwan JR, Landewé RB, Lassere MN, Michaud K, Suarez-Almazor M, Silman AJ, Smolen JS, Van der Heijde DM, van Riel PL, Wolfe F, Tugwell PS.

J Rheumatol. 2005 Oct;32(10):2016-24.

PMID:
16206362
4.

Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group.

Alten R, Pohl C, Choy EH, Christensen R, Furst DE, Hewlett SE, Leong A, May JE, Sanderson TC, Strand V, Woodworth TG, Bingham CO 3rd; OMERACT RA Flare Definition Working Group.

J Rheumatol. 2011 Aug;38(8):1745-50. doi: 10.3899/jrheum.110400.

PMID:
21807796
5.

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary.

Bartlett SJ, Bykerk VP, Cooksey R, Choy EH, Alten R, Christensen R, Furst DE, Guillemin F, Halls S, Hewlett S, Leong AL, Lyddiatt A, March L, Montie P, Orbai AM, Pohl C, Voshaar MS, Woodworth TG, Bingham CO 3rd.

J Rheumatol. 2015 Nov;42(11):2185-9. doi: 10.3899/jrheum.141169. Epub 2015 Feb 15. Review.

6.

Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein.

Keeling SO, Landewe R, van der Heijde D, Bathon J, Boers M, Garnero P, Geusens P, El-Gabalawy H, Inman RD, Kraus VB, Kvien TK, Mease PJ, Ostergaard M, Ritchlin C, Syversen SW, Maksymowych WP.

J Rheumatol. 2007 Mar;34(3):623-33. Review.

PMID:
17343310
7.

A tool to identify recent or present rheumatoid arthritis flare from both patient and physician perspectives: the 'FLARE' instrument.

Berthelot JM, De Bandt M, Morel J, Benatig F, Constantin A, Gaudin P, Le Loet X, Maillefert JF, Meyer O, Pham T, Saraux A, Solau-Gervais E, Spitz E, Wendling D, Fautrel B, Guillemin F; STPR group of French Society of Rheumatology.

Ann Rheum Dis. 2012 Jul;71(7):1110-6. doi: 10.1136/ard.2011.150656. Epub 2011 Nov 9.

PMID:
22072015
8.

Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus.

Bartlett SJ, Hewlett S, Bingham CO 3rd, Woodworth TG, Alten R, Pohl C, Choy EH, Sanderson T, Boonen A, Bykerk V, Leong AL, Strand V, Furst DE, Christensen R; OMERACT RA Flare Working Group.

Ann Rheum Dis. 2012 Nov;71(11):1855-60. doi: 10.1136/annrheumdis-2011-201201. Epub 2012 Jul 6.

PMID:
22772326
10.

Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop.

Bingham CO 3rd, Alten R, Bartlett SJ, Bykerk VP, Brooks PM, Choy E, Christensen R, Furst DE, Hewlett SE, Leong A, May JE, Montie P, Pohl C, Sanderson TC, Strand V, Woodworth TG; OMERACT RA Flare Definition Working Group.

J Rheumatol. 2011 Aug;38(8):1751-8. doi: 10.3899/jrheum.110401.

PMID:
21807797
11.

More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions.

Orbai AM, Halls S, Hewlett S, Bartlett SJ, Leong AL, Bingham CO 3rd; RA Flare Group Steering Committee.

J Rheumatol. 2015 Nov;42(11):2182-4. doi: 10.3899/jrheum.141172. Epub 2015 Mar 1. Review.

12.

Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials.

Maksymowych WP, Landewe R, Boers M, Garnero P, Geusens P, El-Gabalawy H, Heinegard D, Kraus VB, Lohmander S, Matyas J, Saxne T, van der Heijde D.

J Rheumatol. 2007 Mar;34(3):634-40. Erratum in: J Rheumatol. 2007 Dec;34(12):2506. Krause, Virginia [corrected to Kraus, Virginia B].

PMID:
17343311
13.

Responsiveness of the self-assessed rheumatoid arthritis disease activity index to a flare of disease activity.

Fransen J, Häuselmann H, Michel BA, Caravatti M, Stucki G.

Arthritis Rheum. 2001 Jan;44(1):53-60.

14.

Validation of OMERACT preliminary rheumatoid arthritis flare domains in the NOR-DMARD study.

Lie E, Woodworth TG, Christensen R, Kvien TK, Bykerk V, Furst DE, Bingham CO 3rd, Choy EH; OMERACT RA Flare Working Group.

Ann Rheum Dis. 2014 Oct;73(10):1781-7. doi: 10.1136/annrheumdis-2013-203496. Epub 2013 Jul 12.

PMID:
23852690
15.

Remission in rheumatoid arthritis: wishful thinking or clinical reality?

Sesin CA, Bingham CO 3rd.

Semin Arthritis Rheum. 2005 Dec;35(3):185-96.

PMID:
16325659
16.

MCID/Low Disease Activity State Workshop: low disease activity state in rheumatoid arthritis.

Wells G, Boers M, Shea B, Anderson J, Felson D, Johnson K, Kirwan J, Lassere M, Robinson V, Simon L, Strand V, van Riel P, Tugwell P.

J Rheumatol. 2003 May;30(5):1110-1. Review.

PMID:
12734918
17.

Preliminary definition of disease flare in juvenile rheumatoid arthritis.

Brunner HI, Lovell DJ, Finck BK, Giannini EH.

J Rheumatol. 2002 May;29(5):1058-64.

PMID:
12022323
18.

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, et al.

Arthritis Rheum. 1995 Jun;38(6):727-35.

PMID:
7779114
19.

Generic quality-of-life assessment in rheumatoid arthritis.

Tugwell P, Idzerda L, Wells GA.

Am J Manag Care. 2007 Dec;13 Suppl 9:S224-36. Review.

20.

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J, Keystone E, Koch G, Kvien TK, Martin-Mola E, Matucci-Cerinic M, Michaud K, O'Dell J, Paulus H, Pincus T, Richards P, Simon L, Siegel J, Smolen JS, Sokka T, Strand V, Tugwell P, van der Heijde D, van Riel P, Vlad S, van Vollenhoven R, Ward M, Weinblatt M, Wells G, White B, Wolfe F, Zhang B, Zink A, Felson D.

Ann Rheum Dis. 2008 Oct;67(10):1360-4. doi: 10.1136/ard.2008.091454.

PMID:
18791055

Supplemental Content

Support Center